Top catalysts for Canada’s TSX Composite Index
Canadian stocks are firing on all cylinders this year, despite the headwinds brought by Donald Trump’s tariffs. The TSX Composite Index jumped to a record high of $29,283, up by…
Why Barclays turned positive on General Motors and Aptiv
The outlook for the US auto industry is improving, according to Barclays, which upgraded shares of General Motors and Aptiv on Friday. Analyst Dan Levy raised his rating on both…
Zeta Global stock golden cross points to a surge soon
Zeta Global stock price has rebounded in the past few months, moving from a low of $10 in April to $20.7 today. It is hovering at its highest point since…
IONQ stock RSI surpasses 75 as UK approves Oxford Ionics deal—but don’t sell
UK’s Investment Security Unit (ISU) has cleared IonQ Inc’s (NYSE: IONQ) more than $1.0 billion acquisition of Oxford Ionics. The quantum computing stock soared nearly 20% on the news today.The…
Gemini stock to debut on Nasdaq after 20× oversubscribed $425M IPO
Gemini stock is all set to debut on the Nasdaq, marking a significant milestone in the cryptocurrency sector by being oversubscribed 20 times and raising $425 million at $28 per…
Tesla stock is skyrocketing 7% today as Tesla Chair calls Musk a ‘generational leader’
Tesla stock rose over 7% on Friday, lifted by renewed investor optimism despite concerns over weak sales, stretched valuations, and Chief Executive Elon Musk’s strategic shift toward artificial intelligence and…
Tempus AI stock is cheap as Murrey Math Lines points to more gains
Tempus AI stock price surged to a record high on Wednesday after the healthcare-focused artificial intelligence company announced a major breakthrough from the Food and Drug Administration (FDA). It jumped…
Evening digest: arrest made in Charlie Kirk’s murder, Nvidia-OpenAI deal, G7 tariff push
Friday’s news wrap covers major developments shaping global politics, technology, and security. A suspect has been arrested in the murder of conservative activist Charlie Kirk, sparking outrage.Meanwhile, the FTC is…
AstraZeneca pauses £200mn Cambridge investment amid UK pharma uncertainty
AstraZeneca has become the latest major drugmaker to scale back investment in the United Kingdom, pausing a planned £200 million ($271 million) expansion of its Cambridge research site. The move,…
Top three ‘cash rich’ stocks that can weather any market downturn
With US equities hovering near record levels and economics indicators flashing warning signs – Morgan Stanley is urging investors to seek shelter in companies with robust free cash flows.According to…